Publications by authors named "Amanda Hooper"

Claim this Profile
D
Diverse Obesity Trajectories in a Family Including Identical Twins with a Pathogenic MC4R Variant.
Jane Jia Xin Lim, Amanda J Hooper, Joan Khoo, Wann Jia Loh

Obes Facts· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidental Finding of Severe Hypertriglyceridaemia and Diagnosis of Familial Chylomicronaemia Syndrome in a Family.
V Thadchanamoorthy, Kavinda Dayasiri, Hemika Yoganathan, S I Majitha, Amanda J Hooper

J Paediatr Child Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the clinical progress of muvalaplin for reducing lipoprotein(a).
Amanda J Hooper, P Mihika S Fernando, John R Burnett

Expert Opin Investig Drugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the detection of familial hypercholesterolaemia in general practice: A model for supporting genetic cascade testing in the community.
Jing Pang, Wendy Barnett, Jane Purdie, Jennifer A Della-Vedova, Annmarie Woodward, Amanda J Hooper

Eur J Hum Genet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the clinical development of zerlasiran, a small-interfering RNA for elevated lipoprotein(a).
Xuan L Tang, Amanda J Hooper, John R Burnett

Expert Opin Investig Drugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-reporting aldosterone by mass spectrometry and immunoassay in the seated saline suppression test may enhance subtype classification of patients with primary aldosteronism.
Nicola Sawyer, Paul Glendenning, Markus P Schlaich, Amanda J Hooper, Damon A Bell

Pathology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging ANGPTL3-directed therapies for hyperlipidemia: insights from two recent phase II trials.
Amanda J Hooper, Thusyanthy Parameswaran, John R Burnett

Expert Opin Investig Drugs· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PUTRA-CV study protocol: a multicentre observational study of ethnic-specific genetic variants and dietary patterns in relation to lipoprotein(a) levels and their association with coronary artery disease severity in Malaysian adults.
Sangitha Pannirselvam, Subashini C Thambiah, Geeta Appannah, King Hwa Ling, Intan Nureslyna Samsudin, Amanda J Hooper

BMJ Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lomitapide for the treatment of pediatric homozygous familial hypercholesterolemia.
Amanda J Hooper, Damon A Bell, John R Burnett

Expert Opin Pharmacother· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sepiapterin for the treatment of phenylketonuria.
Robin A Williams, Damon A Bell, Amanda J Hooper, John R Burnett

Expert Opin Pharmacother· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of recaticimab for the treatment of hypercholesterolemia.
Xuan L Tang, Amanda J Hooper, John R Burnett

Expert Opin Biol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunistic Detection of Phytosterolemia During Genetic Testing for FH: Case Series and Contextual Review.
Wann Jia Loh, Dick C Chan, Jing Pang, Amanda J Hooper, Damon Bell

J Clin Endocrinol Metab· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to the letter to the editor: 'Olezarsen, a liver-directed ASO therapy for hypertriglyceridemia'.
Amanda J Hooper, Damon A Bell, John R Burnett

Expert Opin Pharmacother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the clinical potential of plozasiran, an siRNA therapy for severe hypertriglyceridemia.
Xuan L Tang, Amanda J Hooper, John R Burnett

Expert Opin Investig Drugs· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homozygous LPL and GPIHBP1 variants causing familial chylomicronaemia syndrome in Sri Lankan children.
Fasilaas Kiyamudeen, Madubashini Rajapaksha, Navoda Atapattu, Srinika D Kularatne, Sabine Schröder, Amanda J Hooper

Pathology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olezarsen, a liver-directed ASO therapy for hypertriglyceridemia.
Amanda J Hooper, Damon A Bell, John R Burnett

Expert Opin Pharmacother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VERVE-101, a CRISPR base-editing therapy designed to permanently inactivate hepatic PCSK9 and reduce LDL-cholesterol.
Amanda J Hooper, Xuan L Tang, John R Burnett

Expert Opin Investig Drugs· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lepodisiran, an siRNA targeting lipoprotein(a) for the potential future treatment of cardiovascular disease.
P Mihika S Fernando, Amanda J Hooper, John R Burnett

Expert Opin Investig Drugs· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor From Hooper: "Cardio-cerebrovascular Outcomes in Maturity Onset Diabetes of the Young, Type 1 Diabetes, and Type 2 Diabetes: A Prospective Cohort Study".
Amanda J Hooper

J Clin Endocrinol Metab· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia.
Wann Jia Loh, Jing Pang, Anindita Chakraborty, Natalie C Ward, Dick C Chan, Amanda J Hooper

J Clin Lipidol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and imaging features of women with polygenic partial lipodystrophy: a case series.
Wann Jia Loh, Jadegoud Yaligar, Amanda J Hooper, Suresh Anand Sadananthan, Yeshe Kway

Nutr Diabetes· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential of muvalaplin as a lipoprotein(a) inhibitor.
Amanda J Hooper, P Mihika S Fernando, John R Burnett

Expert Opin Investig Drugs· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment.
John R Burnett, Amanda J Hooper

Expert Opin Investig Drugs· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis